{"schema_version": 1, "id": "ms-nonmetropolitan-area/life-sciences/2026-09", "product": "Labor Market Pulse", "metro": {"geography_id": 267, "label": "MS NONMETROPOLITAN AREA", "slug": "ms-nonmetropolitan-area"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-09", "public_after": "2026-09-01", "frozen_at": "2026-10-09T13:22:24.440981+00:00", "headline": "Nonmetro Mississippi pays regulatory and clinical talent above national rates.", "headline_summary": "Regulatory Affairs Specialists command $111,675 locally versus a flat $104,000 nationally, while CRA pay runs $99,605 against $90,956 \u2014 a scarcity premium showing up even as generic pharma manufacturing employment keeps shrinking statewide.", "key_indicators": [{"label": "County unemployment spread", "value": "11.7% vs 3.1%", "context": "Jefferson County vs Jones County, Aug 2026"}, {"label": "Statewide job openings rate", "value": "5.4%", "context": "vs 4.5% national rate, Oct 2025"}, {"label": "Regulatory Affairs advertised pay", "value": "$111,675", "context": "vs $104,000 national, flat YoY"}, {"label": "MS employment growth forecast", "value": "-0.1%/yr", "context": "Projected annually, 2026-2030"}], "takeaways": [{"headline": "Regulatory Affairs pay in this metro is outrunning the national rate.", "body": "Advertised Regulatory Affairs Specialist pay sits at $111,675 locally against a flat $104,000 nationally, a reversal of the usual nonmetro discount. Local scarcity for regulatory talent capable of navigating faster FDA pathways appears to be forcing premiums even in a thin labor market."}, {"headline": "Clinical Research Associate pay premium signals a thin specialist bench.", "body": "Metro CRA pay at $99,605 runs roughly 9% above the $90,956 national median, an unusual inversion for a nonmetro geography. This likely reflects a small qualified pool stretched across Mississippi's limited clinical trial infrastructure, raising retention stakes for any employer running active studies here."}, {"headline": "Lab Technician pay erosion tracks broader manufacturing softness.", "body": "Advertised pay for Lab Technicians fell moderately both locally ($40,492) and nationally ($47,402), consistent with declining generic pharma manufacturing employment in the state. Entry-level technical roles may be absorbing the weakest demand signal in an otherwise tightening specialist market."}, {"headline": "Outsourcing math favors CDMOs over local GMP expansion.", "body": "Mississippi's generic pharmaceutical manufacturing workforce has shrunk on an annualized basis through 2026 while statewide employment is projected to decline 0.1% annually through 2030. Build-vs-outsource decisions in this metro increasingly favor CDMO capacity in stronger labor markets over internal manufacturing investment."}], "local_conditions": "Nonmetro Mississippi's labor pool remains structurally uneven \u2014 Jefferson County unemployment sits at 11.7% and Issaquena at 9.9%, while Lafayette and Jones counties hold near 3.1-3.2%, reflecting a fragmented rural economy rather than a single coherent labor market. Statewide job openings ran at 5.4% as of October 2025, above the 4.5% national rate, even as Mississippi's generic pharmaceutical manufacturing employment has continued an annualized decline through 2026.", "implications": "Wide county-level unemployment dispersion means nonmetro Mississippi offers no uniform labor supply story \u2014 recruitment strategy should treat high-unemployment counties (Jefferson, Issaquena, Holmes) and tighter labor counties (Jones, Lafayette) as distinct talent markets with different sourcing timelines. Declining generic pharma manufacturing headcount locally, paired with above-average statewide job-opening friction, strengthens the case for CDMO partnerships over new GMP buildout in this geography. Consider evaluating site-location and outsourcing decisions against county-level labor availability data rather than statewide averages alone.", "looking_ahead": [{"category": "Worth watching", "body": "County-level unemployment divergence (11.7% Jefferson vs 3.1% Jones) may widen further as manufacturing WARN activity continues statewide. Track whether displaced manufacturing workers migrate toward higher-unemployment counties seeking life sciences openings."}, {"category": "Emerging pressure point", "body": "National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions, not execution-critical roles like CMC and regulatory. Watch whether any released specialist talent becomes available to Mississippi-based employers via remote or relocation-friendly postings."}, {"category": "Potential inflection point", "body": "Hitachi Energy's state investment announcement signals continued manufacturing-sector interest in Mississippi despite life sciences manufacturing softness. Monitor whether this draws skilled technical labor away from pharma/biotech competitors in adjacent counties."}, {"category": "Early indicator", "body": "Statewide job openings rate (5.4%) continues to exceed the national rate, suggesting hiring friction may persist into Q4. Recruitment timelines for regulatory and clinical roles should be budgeted with this above-average friction in mind."}], "roles": [{"role": "Research Scientist", "data_scope": "state_rollup", "metro_p25": 109700.0, "metro_p50": 115593.6, "metro_p75": 117067.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 131354.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 57993.0, "metro_p50": 99605.0, "metro_p75": 106220.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 90955.8, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "state_rollup", "metro_p25": 39520.0, "metro_p50": 40492.0, "metro_p75": 46278.75, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 47402.2, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Regulatory Affairs Specialist", "data_scope": "state_rollup", "metro_p25": 78759.0, "metro_p50": 111675.0, "metro_p75": 111675.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 104000.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Clinical Data Manager", "data_scope": null, "metro_p25": null, "metro_p50": null, "metro_p75": null, "metro_trend_direction": null, "metro_trend_magnitude": null, "national_p50": 123031.0, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Biostatistician", "data_scope": "state_rollup", "metro_p25": 98529.0, "metro_p50": 135547.8, "metro_p75": 144198.75, "metro_trend_direction": null, "metro_trend_magnitude": null, "national_p50": 133322.0, "national_trend_direction": "up", "national_trend_magnitude": "moderate"}, {"role": "Validation Engineer", "data_scope": "state_rollup", "metro_p25": 105020.0, "metro_p50": 105020.0, "metro_p75": 105020.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 108377.0, "national_trend_direction": "up", "national_trend_magnitude": "moderate"}], "industry_snapshot": [], "citations": [], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "October 2026", "files": {"html": "ms-nonmetropolitan-area/life-sciences/2026-09.html", "pdf": "ms-nonmetropolitan-area/life-sciences/2026-09.pdf"}, "published_at": "2026-10-09T14:33:30.787506+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/ms-nonmetropolitan-area/life-sciences/2026-09.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/ms-nonmetropolitan-area/life-sciences/2026-09.pdf"}